Brendan O'Grady
Directeur Général chez AUSPEX PHARMACEUTICALS INC
Profil
Brendan P.
O'Grady is currently the Chief Executive Officer at Auspex Pharmaceuticals, Inc. He is also the Chief Executive Officer & Director at Assertio Holdings, Inc. and a Director at the Association for Accessible Medicines.
Previously, he served as the CEO-Global Formulations Business at Glenmark Pharmaceuticals Ltd.
from 2022 to 2024.
He was also a Director at the Pharmaceutical Research & Manufacturers of America.
From 2011 to 2021, O'Grady worked at Teva Pharmaceutical Industries Ltd., where he held the position of EVP-North America Commercial Division from 2017 to 2021.
Additionally, he was the Chief Commercial & Growth Officer at American Well Corp.
from 2021 to 2022.
O'Grady holds an MBA from Baker University, which he obtained in 2004.
He completed his undergraduate studies at the State University of New York College at Geneseo in 1988.
Postes actifs de Brendan O'Grady
| Sociétés | Poste | Début |
|---|---|---|
| AUSPEX PHARMACEUTICALS INC | Directeur Général | - |
| ASSERTIO HOLDINGS, INC. | Directeur Général | 29/05/2024 |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Directeur/Membre du Conseil | - |
Anciens postes connus de Brendan O'Grady
| Sociétés | Poste | Fin |
|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01/02/2024 |
| AMERICAN WELL CORPORATION | Directeur/Membre du Conseil | 19/07/2021 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 15/08/2021 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Directeur/Membre du Conseil | - |
Formation de Brendan O'Grady
| State University of New York College at Geneseo | Undergraduate Degree |
| Baker University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AMERICAN WELL CORPORATION | Technology Services |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| ASSERTIO HOLDINGS, INC. | Health Technology |
| GLENMARK PHARMACEUTICALS LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
